03/02/2020 12:00 AM EST
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 3/2/2020. This nine-page document aims to inform resource planning for contact tracing, quarantine, and monitoring activities for COVID-19 (coronavirus disease) cases within European Union/European Economic Area (EU/EEA) Member States. It describes methods; resource estimation for contact tracing, quarantine, and monitoring activities; options for higher-transmission scenarios; and optional supplementary activities and resources. (PDF)
02/29/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/29/2020. The purpose of this three-page document is to offer guidance to Member States on quarantine measures for individuals in the context of COVID-19 (coronavirus disease). It is intended for those responsible for establishing local or national policy for quarantine of individuals, and adherence to infection prevention and control measures. It details when to use quarantine, and recommendations for implementation of quarantine measures. (PDF)
02/29/2020 12:00 AM EST
Source: U.S. Food and Drug Administration (FDA). Published: 2/29/2020. This eight-page guidance provides a policy for novel coronavirus (COVID-19) molecular diagnostics tests developed and used in laboratories certified to perform high-complexity testing under the Clinical Laboratory Improvement Amendments (CLIA) prior to issuance of emergency use authorizations (EUA) for such tests. It describes an accelerated policy enabling laboratories to use tests they develop faster in order to achieve more rapid testing capacity in the United States. (PDF)
02/28/2020 12:00 AM EST
Source: Evidence Aid. Published: 2/28/2020. This web page, updated on February 28, 2020, provides links to resources from the rapidly expanding and evolving literature about the coronavirus (COVID-19) outbreak. The resources are from U.S. and international agencies, organizations, and publications. (Text)
02/28/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/28/2020. This 40-page report summarizes the World Health Organization-China Joint Mission undertaken to rapidly inform national (China) and international planning on next steps in the response to the ongoing outbreak of the novel coronavirus disease (COVID-19), and on next steps in readiness and preparedness for geographic areas not yet affected. The major findings are described in six sections: the virus, the outbreak, transmission dynamics, disease progression and severity, the China response, and knowledge gaps. (PDF)
02/28/2020 12:00 AM EST
Source: Sphere Project. Published: 2/28/2020. This four-page document reviews emerging practices in the coronavirus (COVID-19) outbreak response to guide users through the relevant parts of the Sphere Handbook. It outlines the underlying principles and the importance of community engagement, as well as a detailed review of the relevant technical guidance in the WASH (Water, Sanitation, and Hygiene) and Health chapters. (PDF)
02/28/2020 12:00 AM EST
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 2/28/2020. This 13-page document provides support to healthcare workers managing suspected or confirmed cases of novel coronavirus 2019 (COVID-19). It aims to present the minimal set of personal protective equipment (PPE) required for managing suspected or confirmed COVID-19 cases; make healthcare workers aware of the critical aspects of the donning and doffing of PPE; and strengthen occupational safety in healthcare workers for patients suspected of, or confirmed with, COVID19. (PDF)
02/27/2020 12:00 AM EST
Source: International Air Transport Association (IATA). Published: 2/27/2020. This web page, updated on February 27, 2020, provides information for the airline industry and the traveling public about air transport and communicable diseases. It discusses the novel coronavirus (COVID-19), Ebola, and measles. (Text)
02/27/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/27/2020. This web page, updated on February 27, 2020, provides interim guidance for healthcare professionals regarding the novel coronavirus (COVID-19) in three sections: Criteria to Guide Evaluation of Patients Under Investigation (PUI) for COVID-19; Recommendations for Reporting, Testing, and Specimen Collection; and Interim Healthcare Infection Prevention and Control Recommendations for Patients Under Investigation for COVID-19. (Text)
02/27/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/27/2020. This three-page document, updated on February 27, 2020, provides guidance to Member States on implementation of global surveillance of COVID-19. The objectives of this global surveillance are to monitor trends of the disease where human-to-human and/or zoonotic transmission occurs; rapidly detect new cases in countries where the virus is not circulating; provide epidemiological information to conduct risk assessment at the national, regional, and global level; and provide epidemiological information to guide response measures. (PDF)
02/27/2020 12:00 AM EST
Source: Australian Government. Published: 2/27/2020. This document, updated on February 27, 2020, provides Public Health Laboratory Network (PHLN) guidance on laboratory testing for COVID-19, including handling of specimens in the laboratory, and COVID-19-specific testing. Where applicable, laboratories should consult with their state/territory communicable diseases agency to seek advice on which laboratories can provide COVID-19 testing; determine appropriate specimen type, collection, and transport; and facilitate contact management if indicated. (PDF)
02/27/2020 12:00 AM EST
Source: Network for Public Health Law. Published: 2/27/2020. In 2017, 272 Pennsylvanians under the age of 24 died of opioid overdose, and overdose among this age group has sharply increased since 2015. This three-page Harm Reduction and Overdose Prevention Fact Sheet discusses whether it is permissible to prescribe the medication naloxone to minors in Pennsylvania. It discusses how opioid overdose is reversible through the timely administration of naloxone and, where needed, the provision of other emergency care. (PDF)
02/27/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/27/2020. This seven-page document summarizes World Health Organization recommendations for the rational use of personal protective equipment (PPE) for novel coronavirus (COVID-19), in health care and community settings, including the handling of cargo. It is intended for those involved in the distribution and management of PPE, as well as public health authorities and individuals in health care and community settings, to understand when PPE use is most appropriate. (PDF)
02/27/2020 12:00 AM EST
Source: Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]. Published: 2/27/2020. This web page offers American hospital administrators and clinicians specific judgment on what hospitals should do to prepare for a novel coronavirus (COVID-19) pandemic. It presents the argument for urgent preparedness, provides a table of Health and Human Services pandemic planning assumptions, lists top priorities and specific priority actions to be taken, and discusses how to proceed. (Text)
02/26/2020 12:00 AM EST
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 2/26/2020. During this one-hour, 31-minute webinar from TRACIE (Technical Resources, Assistance Center, and Information Exchange), speakers discuss guidance, resources, and lessons learned to help healthcare coalitions develop a pediatric surge annex. They provide an overview of the American Academy of Pediatrics (AAP) and Pediatric Centers of Excellence; discuss the Eastern Great Lakes Pediatric Consortium for Disaster Response; and provide information about pediatric identification and tracking. (Video or Multimedia)
02/26/2020 12:00 AM EST
Source: National Nurse-Led Care Coalition (NNCC). Published: 2/26/2020. This one-hour webinar discusses what’s new based on the Centers for Medicare and Medicaid Services' Regulatory Provisions to Promote Program Efficiency, Transparency, and Burden Reduction Final Rule. Topics include Risk Assessment and Planning; All-Hazards Approach; Policies and Procedures; Communication Plans; Training and Testing Programs; and Testing Changes with Burden Reduction. (Video or Multimedia)
02/25/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/25/2020. This interim guidance, updated on February 25, 2020 is intended to assist with assessment of risk, monitoring, and work restriction decisions for healthcare personnel with potential exposure to coronavirus disease 2019 (COVID-19). It includes a table for Epidemiologic Risk Classification for Asymptomatic Healthcare Personnel Following Exposure to Patients with Coronavirus Disease 2019 (COVID-19) Infection or their Secretions/Excretions in a Healthcare Setting, and their Associated Monitoring and Work Restriction Recommendations. (Text)
02/25/2020 12:00 AM EST
Source: United Kingdom Department of Health (DH). Published: 2/25/2020. This guidance will assist social, community, and residential care employers in providing advice to their staff on the novel coronavirus (COVID-19); how to help prevent spread of all respiratory infections, including COVID-19; what to do if someone suspected or confirmed to have COVID-19 has been in a health or social care setting; what advice to give to individuals who have traveled to specific areas; risk assessments for undertaking domiciliary visits or providing care in residential settings; and actions to take if staff come into contact with someone who is self-isolating or is a possible or confirmed case of COVID-19. (Text)
02/24/2020 12:00 AM EST
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/24/2020. This resource, updated on February 24, 2020, provides information about legal authorities for isolation and quarantine, which are public health practices used to stop or limit the spread of disease. Federal isolation and quarantine are authorized for these communicable diseases: Cholera, diphtheria, infectious tuberculosis, plague, smallpox, yellow fever, viral hemorrhagic fevers (including Ebola), severe acute respiratory syndromes, and flu that can cause a pandemic. (Text)
02/23/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/23/2020. This web page, updated on February 23, 2020, provides answers to questions about coronaviruses, a large family of viruses that are known to cause illness ranging from the common cold to more severe diseases such as coronavirus disease (COVID-19), Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Questions cover topics that include COVID-19 symptoms, vaccines, antibiotics, and incubation period. (Text)
02/12/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/12/2020. This 20-page guidance document outlines the measures to be taken at country level to contain the novel coronavirus (COVID-19), and will be updated with further guidance if the epidemiological situation changes. It outlines the priority steps and actions to be included in COVID‑19 Country Preparedness and Response Plan (CPRP) across the major areas of the public health preparedness and response: Country-level coordination, planning, and monitoring; risk communication and community engagement; surveillance, rapid-response teams, and case investigation; points of entry; national laboratories; infection prevention and control; case management; and operations support and logistics. (PDF)
02/04/2020 12:00 AM EST
Source: Public Health Agency of Canada (PHAC). Published: 2/4/2020. This biosafety advisory is being provided by the Public Health Agency of Canada (PHAC) to assist clinical, diagnostic, and research laboratories in implementing proper biosafety procedures where samples containing the novel coronavirus (COVID-19) are handled. It provides background, and a table summarizes Biosafety Requirements. This page also provides links to other laboratory biosafety and biosecurity information. (Text)
02/03/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/3/2020. This 28-page strategic preparedness and response plan outlines the public health measures that the international community stands ready to provide to support all countries to prepare for and respond to 2019‑nCoV. The document takes what has been learned so far about the virus, and translates that knowledge into strategic action that can guide the efforts of all national and international partners when developing context‑specific national and regional operational plans. (PDF)
02/01/2020 12:00 AM EST
Source: Medical Mission Institute. Published: 2/2020. This toolbox, updated in February 2020, provides information and materials about rapid response to diseases and outbreaks, including situation reports about COVID-19 (coronavirus disease), plague, cholera, Marburg Virus, and Yellow Fever. It provide clinical guidelines, including for COVID-19,chikungunya, dengue, Ebola, and Zika; information about communication and training; and prevention and control information. (Text)
02/01/2020 12:00 AM EST
Source: World Health Organization (WHO). Published: 2/2020. All personnel responding to outbreaks of acute respiratory infections (ARIs) need to have the basic knowledge and skills to mount an effective response. They need to understand what ARIs are, how they are transmitted, how to assess the risk of infection, and to understand basic hygiene measures to protect themselves. This learning package consists of four modules with videos and downloadable presentations. (Video or Multimedia)
02/01/2020 12:00 AM EST
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 2/2020. This web page provides links to novel coronavirus (COVID-19) technical documents for these topics: Biosafety, Detection and Diagnosis, Hospital Readiness, Infection Prevention and Control, and Requirements and Technical Specifications - Personal Protective Equipment (PPE). (Text)
02/01/2020 12:00 AM EST
Source: WebJunction. Published: 2/2020. This 26-page report, published with OCLC and the Public Library Association, offers strategies for public libraries to consider as they determine a local response to the nationwide opioid crisis. It provides options, ideas, and resources to support libraries as they develop response strategies, and encourages libraries to evaluate local health data; seek community partners; educate staff and community members on the issue; consider the need for staff care; and offer programs and services that support local needs. (PDF)
02/01/2020 12:00 AM EST
Source: Nigeria Centre for Disease Control (NCDC). Published: 2/2020. This one-page document provides definitions for COVID-19 (coronavirus disease) related to suspect case, probably case, and confirmed case. (PDF)
01/01/2020 12:00 AM EST
Source: World Bank. Published: 1/2020. This 48-page report leverages behavioral science to identify key entry points to improve early warning systems (EWS) and enable people to evacuate to safe locations before adverse natural events, including hurricanes. The behavioral approach allows for the detection of barriers related to psychological and social factors that go beyond access and cost. The objective of this report is to understand, through a behavioral approach, the structural and behavioral barriers that limit evacuation decisions in Haiti. (PDF)
01/01/2020 12:00 AM EST
Source: Child Care Aware of America. Published: 1/2020. This two-page document is a checklist of questions for child care providers to review about emergency plans, preparing for the weather, evacuation method, evacuation location, emergency supply kit, meeting the needs of infants and toddlers, and parent communication and policies. (PDF)
10/01/2019 12:00 AM EDT
Source: Enhancing Learning and Research for Humanitarian Assistance (ELRHA). Published: 10/2019. This 27-page review identifies ethical challenges in the scholarly literature pertaining to the conduct of research during the 2014-2016 West Africa Ebola outbreak. Its aim was to catalogue anticipated and unexpected ethical challenges faced by research teams in the course of planning and implementing studies during this public health emergency, with the goals of producing a concise record of those that can inform preparedness for research in future similar events. (PDF)
10/01/2019 12:00 AM EDT
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 10/2019. The purpose of this 58-page publication is to provide a framework for planning and implementing Aedes aegypti surveillance, prevention, and control activities through risk stratification to support the development of potential operational scenarios at the local level. Arboviral diseases such as dengue, chikungunya, and Zika fever, are transmitted mainly by the Aedes aegypti and A. albopictus mosquitoes. Operational scenarios in this document serve as a reference for selecting the best tools for vector control and using them more efficiently. (PDF)
.png)
No hay comentarios:
Publicar un comentario